Relationships between angry-impulsive personality traits and genetic polymorphisms of the dopamine transporter

Biological Psychiatry

Volumn 66, Issue 8, 2009, Pages 717-721

  Joyce, Peter R ^a   McHugh, Patrick C ^a   Light, Katrina J ^a   Rowe, Sarah ^a   Miller, Allison L ^a   Kennedy, Martin A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Angry impulsive; Borderline personality disorder; Dopamine transporter

Indexed keywords

DOPAMINE TRANSPORTER; SLC6A3 PROTEIN, HUMAN;

ADULT; ALLELE; ANGER; ARTICLE; BIOLOGICAL MODEL; BORDERLINE STATE; DEPRESSION; DISEASE ASSOCIATION; FAMILY STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MOOD DISORDER; PERSONALITY; PERSONALITY DISORDER; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SCREENING; GENETICS; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ALLELES; ANGER; BORDERLINE PERSONALITY DISORDER; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; MOOD DISORDERS; PERSONALITY; POLYMORPHISM, GENETIC;

EID: 67349232523     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.03.005     Document Type: Article

References (35)

1. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S (2001): The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1:152-156.
2. Bannon MJ, Michelhaugh SK, Wang J, Sacchetti P (2001): The human dopamine transporter gene: Gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacology 11:449-455.
3. Chen CK, Chen SL, Mill J, Huang YS, Lin SK, Curran S, et al. (2003): The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol Psychiatry 8:393-396.
4. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, et al. (2001): Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 6:425-428. (Pubitemid 32566092)
5. Doucette-Stamm LA, Blakely DJ, Tian J, Mockus S, Mao JI (1995): Population genetic study of the human dopamine transporter gene (DAT1). Genet Epidemiol 12:303-308.
6. Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B, et al. (2000): Association of smoking and personality with a polymorphism of the dopamine transporter gene: Results from a community survey. Am J Med Genet 96:331-334.
7. Mill J, Asherson P, Browes C, D'Souza U, Craig I (2002): Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.AmJ Med Genet 114:975-979.
8. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, et al. (1997): Allelic association of a dopamine transporter gene polymorphism in alco-hol dependence with withdrawal seizures or delirium. Biol Psychiatry 41:299-304.
9. Ujike H, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y, et al. (2003): Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J 3:242-247.
10. Young SE, Smolen A, Corley RP, Krauter KS, DeFries JC, Crowley TJ, et al. (2002): Dopamine transporter polymorphism associated with externalizing behavior problems in children. Am J Med Genet 114:144-149.
11. Joyce PR,McHughPC, McKenzie JM, Sullivan PF, Mulder RT, Luty SE, et al. (2006):Adopaminetransporterpolymorphismisarisk factor for borderline personality disorder in depressed patients. Psychol Med 36:807-813.
12. Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbott RM, Stevens IF (2002): Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Aust N Z J Psychiatry 36:384-391.
13. Luty SE, Carter JD, McKenzie JM, Rae AM, Frampton CM, Mulder RT, Joyce PR (2007): Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry 190:496-502.
14. Zanarini MC, Frankenburg FR, Hennen J, Silk KR (2003): The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry 160:274-283.
15. Joyce PR, Mulder RT, Luty SE, McKenzie JM, Sullivan PF, Cloninger CR (2003): Borderline personality disorder in major depression: Symptomatology, temperament, character, differential drug response and six month outcome. Compr Psychiatry 44:35-43.
16. Rowe SL, Jordan J, McIntosh VV, Carter FA, Bulik CM, Joyce PR (2008): Impact of borderline personality disorder on bulimia nervosa. Aust N Z J Psychiatry 42:1021-1029.
17. Mulder RT, Joyce PR (1997): Temperament and the structure of personality disorder symptoms. Psychol Med 27:99-106.
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. (1998): The mini-international neuropsychiatric interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(suppl 20):22-33.
19. Spitzer RL, Williams JB, Gibbon M, FirstMB(1992): The structured clinical interview for DSM-III-R (SCID). I. History, rationale, and description. Arch Gen Psychiatry 49:624-629.
20. Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, et al. (2003): Screening for bipolar disorder in the community. J Clin Psychiatry 64:53-59.
21. Joyce PR, Light KJ, Rowe SL, Kennedy MA (2007): Bipolar disorder not otherwise specified: Comparison with bipolar disorder I/II and major depression. Aust N Z J Psychiatry 41:843-849.
22. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS (1997): User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC: American Psychiatric Publishing.
23. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, et al. (1992): Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106.
24. Sullivan PF, Fifield WJ, Kennedy MA, Mulder RT, Sellman JD, Joyce PR (1997): Novelty seeking and a dopamine transporter gene polymorphism (DAT1). Biol Psychiatry 42:1070-1072.
25. Cloninger CR, Svrakic DM, Przybeck TR (1993): A psychobiological model of temperament and character. Arch Gen Psychiatry 50:975-990.
26. Svrakic DM, Whitehead C, Przybeck TR, Cloninger CR (1993): Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Arch Gen Psychiatry 50:991-999.
27. Depue RA, Slater JF, Wolfstetter-Kausch H, Klein D, Goplerud E, Farr D (1981):Abehavioural paradigm for identifying persons at risk for bipolar depressive disorder: A conceptual framework and five validation studies. J Abnorm Psychol 90:381-437.
28. Joyce PR, Luty SE, McKenzie JM, Mulder RT, McIntosh VV, Carter FA, et al. (2004): Bipolar II disorder: Personality and outcome in two clinical samples. Aust N Z J Psychiatry 38:433-438.
29. Joyce PR, McKenzie JM, Luty SE, Mulder RT, Carter JD, Sullivan PF, Cloninger CR (2003): Temperament, childhood environment and psychopathology as risk factors for avoidant and borderline personality disorders. Aust NZ J Psychiatry 37:756-764.
30. Zanarini MC, Gunderson JG, Marino MF, Schwartz EO, Frankenburg FR (1989): Childhood experiences of borderline patients. Compr Psychiatry 30:18-25.
31. Zanarini MC, Williams AA, Lewis RE, Reich RB, Vera SC, Marino MF, et al. (1997): Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry 154:1101-1106.
32. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR (2009): Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14:60-70.
33. Friedel RO (2004): Dopamine dysfunction in borderline personality disorder: A hypothesis. Neuropsychopharmacology 29:1029-1039.
34. Schulz SC, Camlin KL, Berry SA, Jesberger JA (1999): Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry 46:1429-1435.
35. van Gaalen MM, van Koten R, Schoffelmeer AN, Vanderschuren LJ (2006): Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 60:66-73.